Stimuline Inj 2mg/mL 2 mg Liquid is a Health Canada–registered veterinary drug (DIN 00564508) held by Distrivet Inc., containing Neostigmine Methylsulfate. Health Canada lists its status as Cancelled Post Market (status date 20 Jun 2006). Nexara Health has matched 94 registrations of Neostigmine Methylsulfate across 4 other regulated markets.
Health Canada registration
| DIN | 00564508 |
|---|---|
| Brand name | Stimuline Inj 2mg/mL |
| Active ingredient | Neostigmine Methylsulfate |
| Strength | 2 mg |
| Dosage form | Liquid |
| Route | Intramuscular ; Subcutaneous |
| Company | Distrivet Inc. |
| Status | Cancelled Post Market — 20 Jun 2006 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Neostigmine Methylsulfate registered in other markets
94 registrations of the same molecule in 4 national registries outside Canada (first 22 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Saudi Arabia | Epistigmin 2.5mg/mL Vial | — | 2.5 | Inactive | SFDA | |
| Saudi Arabia | Neostigmine 2.5mg-mL Amp | — | 2.5 | Inactive | SFDA | |
| Saudi Arabia | Neostigmine Methylsulfate 0.5 mg/mL Ampoule | — | 0.5 | Inactive | SFDA | |
| Taiwan | Correctoron (Eye Drops) | Saishunka Pharm.co. Ltd. | 點眼液劑 | 已註銷 | TFDA | |
| Taiwan | Eyehelp Eye Drops 0.01% | 麥迪森醫藥股份有限公司桃園廠 | 點眼液劑 | Registered | TFDA | |
| Taiwan | Eyesmin Eye Drops (Neostigmine Methylsulfate) "Oasis" | 綠洲化學工業有限公司 | 點眼液劑 | Registered | TFDA | |
| Taiwan | Injectio Neostigminae Methylsulfatis 0.025% "Y.y." | 應元化學製藥股份有限公司 | 注射劑 | 已註銷 | TFDA | |
| Taiwan | Neostigmine Injection | Cooper S. A. | 注射劑 | 已註銷 | TFDA | |
| Taiwan | Neostigmine Injection "Astar" | 安星製藥股份有限公司 | 注射劑 | Registered | TFDA | |
| Taiwan | Neostigmine Injection "Chi Sheng" | 濟生醫藥生技股份有限公司 | 注射劑 | Registered | TFDA | |
| Taiwan | Neostigmine Methyl Sulfate "Dolder" | Dolder Ltd. | （粉） | 已註銷 | TFDA | |
| United Arab Emirates | Neostigmine Methylsulfate (Caplin) 5 mg/10 mL (0.5 mg/mL) | Caplin Steriles Limited, India, Gummidipoondi | 0.5mg/ml | Injection | Active | EDE |
| United Arab Emirates | RAYSTIGMIN 0.25 % (2.5 mg/ml) | EGYPTIAN INTERNATIONAL PHARMACEUTICAL INDUSTRIES CO. (E.I.P.I.CO), Egypt, Tenth of Ramadan City | 2.5 mg/ml | Injection | Active | EDE |
| United Arab Emirates | RAYSTIGMIN 0.5 mg/ml | EGYPTIAN INTERNATIONAL PHARMACEUTICAL INDUSTRIES CO. (E.I.P.I.CO), Egypt, Tenth of Ramadan City | 0.5/ml | Injection | Active | EDE |
| United States | Bloxiverz | Exela Pharma Sciences, LLC | Injection | listed | FDA NDC | |
| United States | neostigmine methylsulfate | Camber Pharmaceuticals Inc. | Injection | listed | FDA NDC | |
| United States | neostigmine methylsulfate | Camber Pharmaceuticals Inc. | Injection | listed | FDA NDC | |
| United States | neostigmine methylsulfate | Meitheal Pharmaceuticals Inc. | Injection | listed | FDA NDC | |
| United States | neostigmine methylsulfate | Meitheal Pharmaceuticals Inc. | Injection | listed | FDA NDC | |
| United States | Neostigmine methylsulfate | Xiromed LLC | Injection | listed | FDA NDC | |
| United States | Neostigmine methylsulfate | Gland Pharma Limited | Injection | listed | FDA NDC | |
| United States | Neostigmine methylsulfate | Gland Pharma Limited | Injection | listed | FDA NDC |
See every manufacturer of Neostigmine Methylsulfate worldwide →
Regulator price references for Neostigmine Methylsulfate
Published list or reimbursement prices for Neostigmine Methylsulfate presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Saudi Arabia | Epistigmin 2.5mg/mL Vial | 2.5mg/1ml | 7.75 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Neostigmine Methylsulfate 0.5 mg/mL Ampoule | 0.5mg/1ml | 13.75 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Neostigmine 2.5mg-mL Amp | 2.5mg | 14.75 SAR | public | SFDA | 2026-09-01 | |
| United Arab Emirates | RAYSTIGMIN 0.5 mg/ml | 0.5mg/1ml | 5 Glass Ampoules (1 mL) | 16.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | RAYSTIGMIN 0.25 % (2.5 mg/ml) | 2.5mg/1ml | 1 Glass Vial (5 mL) | 50.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | Neostigmine Methylsulfate (Caplin) 5 mg/10 mL (0.5 mg/mL) | 0.5mg/1ml | 10's (10 ml x 10 Multiple Dose Glass Vials) | 241.00 AED | public | EDE | 2026-08-31 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Stimuline Inj 2mg/mL (DIN 00564508) marketed in Canada?
No. Health Canada lists DIN 00564508 as Cancelled Post Market as of 20 Jun 2006.
Who holds the Canadian licence for this product?
Distrivet Inc. is the company of record in the Health Canada Drug Product Database.
Is Neostigmine Methylsulfate registered outside Canada?
Yes — Nexara Health has matched 94 registrations in 4 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 00564508, status date 2006-06-20; national medicine registries: EDE, FDA NDC, SFDA, TFDA; price sources: EDE, SFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 00564508, status date 2006-06-20; national medicine registries: EDE, FDA NDC, SFDA, TFDA; price sources: EDE, SFDA.
Health Canada Drug Product Database (DPD), DIN 00564508, status date 2006-06-20; national medicine registries: EDE, FDA NDC, SFDA, TFDA; price sources: EDE, SFDA. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.